<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Cuprina Holdings (cayman) Limited — News on 6ix</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares</link>
<description>Latest news and press releases for Cuprina Holdings (cayman) Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 22 May 2026 14:50:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68355ac678dffbe2df0eb9f0.webp</url>
<title>Cuprina Holdings (cayman) Limited</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares</link>
</image>
<item>
<title>Cuprina Holdings announces 1-for-8 Share Consolidation</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-announces-1-for-8-share-consolidation</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-announces-1-for-8-share-consolidation</guid>
<pubDate>Fri, 22 May 2026 14:50:00 GMT</pubDate>
<description>SINGAPORE, May 22, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that it plans to implement a 1-for-8 share consolidation of its Class A ordinary shares (“Class A Ordinary Shares”) and Class B ordinary shares (“Class B Ordinary Shares”) (the "Share Consolidation"), effective on or</description>
</item>
<item>
<title>Super Copper Appoints Andrés Encina as Country Manager, Chile</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/super-copper-appoints-andres-encina-as-country-manager-chile-1</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/super-copper-appoints-andres-encina-as-country-manager-chile-1</guid>
<pubDate>Tue, 31 Mar 2026 13:00:00 GMT</pubDate>
<description>SUPER COPPER CORP. (CSE: CUPR) (OTCQB: CUPPF) (FSE: N60) ("Super Copper" or the "Company") is pleased to announce the appointment of Andrés Encina as Country Manager, Chile, effective immediately. Mr. Encina will be responsible for leading the Company's on-the-ground operations, permitting coordination, contractor management, and field execution across its flagship Cordillera Cobre and Castilla copper-gold projects in Chile's Atacama region.</description>
</item>
<item>
<title>Super Copper Announces Initiation of Research Coverage by Baader Europe</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/super-copper-announces-initiation-of-research-coverage-by-baader-europe-1</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/super-copper-announces-initiation-of-research-coverage-by-baader-europe-1</guid>
<pubDate>Tue, 17 Mar 2026 13:00:00 GMT</pubDate>
<description>SUPER COPPER CORP. (CSE: CUPR) (OTCQB: CUPPF) (FSE: N60) ("Super Copper" or the "Company"), is pleased to announce that Baader Europe, powered by AlphaValue, has initiated equity research coverage on the Company. The initiation report, authored by Metals & Mining Analyst Varun Sikka and published on March 16, 2026, provides a comprehensive 50-page analysis of the Company's flagship copper-gold exploration projects in Chile's Atacama mining district.</description>
</item>
<item>
<title>Cuprina Holdings Announces Key Regulatory Milestone in Saudi Arabia and Strengthens Global Scientific Advisory Board</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-announces-key-regulatory-milestone-in-saudi-arabia-and-strengthens-global-scientific-advisory-board-3</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-announces-key-regulatory-milestone-in-saudi-arabia-and-strengthens-global-scientific-advisory-board-3</guid>
<pubDate>Wed, 11 Mar 2026 04:00:00 GMT</pubDate>
<description>SINGAPORE, March 11, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing</description>
</item>
<item>
<title>Cuprina Holdings (Cayman) Limited Announces Financial Results for the Six Months Ended June 30, 2025, and Strategic Initiatives for 2026 Growth</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-cayman-limited-announces-133000327</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-cayman-limited-announces-133000327</guid>
<pubDate>Tue, 09 Dec 2025 13:30:00 GMT</pubDate>
<description>SINGAPORE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced its financial results for the six months ended June 30, 2025. "Although our revenue decreased and our net loss increased compared with the same period last year, the first six months of 2025 allowed us to achieve si</description>
</item>
<item>
<title>Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-cayman-limited-announces-133000261</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-cayman-limited-announces-133000261</guid>
<pubDate>Fri, 28 Nov 2025 13:30:00 GMT</pubDate>
<description>SINGAPORE, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, and cosmeceuticals sectors, today announced it has received a letter of noncompliance from The Nasdaq Stock Market LLC ("Nasdaq"), dated November 26, 2025, notifying the Company that based on Cuprina’s closing bid price for the last 30 consecutive business days, the Company no longer</description>
</item>
<item>
<title>Cuprina forms Joint Venture Company with Aiodine Laboratory to Develop and Market Novel Iodine-based Solution as New Wound Care Therapy</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-forms-joint-venture-company-133000329</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-forms-joint-venture-company-133000329</guid>
<pubDate>Tue, 18 Nov 2025 13:30:00 GMT</pubDate>
<description>SINGAPORE, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, and cosmeceuticals sectors, today said it has signed a joint venture (JV) company agreement with Singapore-based Aiodine Laboratory Pte Ltd. (“Aiodine”) to develop, test and market that company’s novel iodine-based disinfectant solution as a treatment for chronic and acute wounds, an</description>
</item>
<item>
<title>Cuprina Signs MOU with Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-signs-mou-singapore-biowaste-124000886</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-signs-mou-singapore-biowaste-124000886</guid>
<pubDate>Mon, 27 Oct 2025 12:40:00 GMT</pubDate>
<description>SINGAPORE, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, and cosmeceuticals sectors, today said it has signed a Memorandum of Understanding (MOU) with Singapore Biowaste Solutions Pte Ltd (SBS), a treater and disposer of bio-medical waste, to explore the integration of Cuprina’s medical waste recycling technology into SBS's existing waste</description>
</item>
<item>
<title>Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-present-live-answer-questions-123000938</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-present-live-answer-questions-123000938</guid>
<pubDate>Mon, 06 Oct 2025 12:30:00 GMT</pubDate>
<description>Individual and institutional investors, advisors, and analysts are invited to attendSINGAPORE, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced that the Company’s management team, including Chief Executiv</description>
</item>
<item>
<title>Cuprina Secures Exclusive Rights to Southeast Asia’s First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-secures-exclusive-rights-southeast-120500853</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-secures-exclusive-rights-southeast-120500853</guid>
<pubDate>Tue, 09 Sep 2025 12:05:00 GMT</pubDate>
<description>SINGAPORE, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced it has secured exclusive licensing rights to Southeast Asia’s first medical waste recycling technology developed under the oversight of the Uni</description>
</item>
<item>
<title>Cuprina Reaffirms Commitment to Shareholders and Patients Following Recent Stock Market Activity</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-reaffirms-commitment-shareholders-patients-120000134</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-reaffirms-commitment-shareholders-patients-120000134</guid>
<pubDate>Mon, 18 Aug 2025 12:00:00 GMT</pubDate>
<description>Singapore, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”) issued the following statement in response to recent unusual trading activity and speculation surrounding the Company. Over the past week, the Company’s stock has experienced heightened trading volatility, which we understand has raised concerns among some shareholders. We want to take this opportunity to reaffirm that Cuprina is a fully operational, legally compliant, and m</description>
</item>
<item>
<title>Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-appoints-dr-ronald-sherman-130000582</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-appoints-dr-ronald-sherman-130000582</guid>
<pubDate>Mon, 21 Jul 2025 13:00:00 GMT</pubDate>
<description>SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“CUPR” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced that Dr. Ronald A. Sherman, a leading innovator in the use of medical maggots to treat chronic wounds, has agreed to join the Company as Medical an</description>
</item>
<item>
<title>Cuprina Provides Update on Research Studies with Three Leading Education Institutes</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-provides-research-studies-three-120000047</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-provides-research-studies-three-120000047</guid>
<pubDate>Mon, 30 Jun 2025 12:00:00 GMT</pubDate>
<description>SINGAPORE, June 30, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today provided an update on progress achieved in relation to three studies carried out with institutes of higher learning. The studies, each one year in length,</description>
</item>
<item>
<title>Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-completes-lab-able-supply-120000400</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-completes-lab-able-supply-120000400</guid>
<pubDate>Wed, 04 Jun 2025 12:00:00 GMT</pubDate>
<description>SINGAPORE, June 04, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“CUPR” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced that its indirect 49%-owned associate, Cuprina MENA Co. Ltd, had completed the set-up of a laboratory, located in Saudi Arabia, equipped to manufac</description>
</item>
<item>
<title>Cuprina Holdings Announces Closing of Underwriter’s Over-Allotment Option in Connection with Initial Public Offering</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-announces-closing-underwriter-170500516</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-announces-closing-underwriter-170500516</guid>
<pubDate>Thu, 08 May 2025 17:05:00 GMT</pubDate>
<description>SINGAPORE, May 08, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced that it closed the sale of an additional 450,000 Class A ordinary shares of the Company, pursuant to the full exercise of the underwriter’s over-</description>
</item>
<item>
<title>Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd.</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-announces-completion-receipt-162900704</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-announces-completion-receipt-162900704</guid>
<pubDate>Mon, 05 May 2025 14:40:00 GMT</pubDate>
<description>SINGAPORE, May 05, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced it had, on April 6, 2025, completed construction of, and obtained ISO 13485 certification and a dealer license for, an operational in-vitro ferti</description>
</item>
<item>
<title>Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-cayman-limited-announces-162700085</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-cayman-limited-announces-162700085</guid>
<pubDate>Fri, 11 Apr 2025 15:07:00 GMT</pubDate>
<description>SINGAPORE, May 05, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“CUPR” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds as well as cosmeceuticals for the health and beauty sector, today announced the closing of its previously announced initial public offering of an aggregate 3,000,000 Class A Ordinary Shares (“the Offering”) at a price of $4.00 per share (“th</description>
</item>
<item>
<title>Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering</title>
<link>https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-cayman-limited-announces-162400545</link>
<guid isPermaLink="true">https://6ix.com/company/cuprina-holdings-cayman-limited-class-a-ordinary-shares/news/cuprina-holdings-cayman-limited-announces-162400545</guid>
<pubDate>Thu, 10 Apr 2025 12:35:00 GMT</pubDate>
<description>SINGAPORE, May 05, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (“CUPR” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds as well as cosmeceuticals for the health and beauty sector, today announced the pricing of its firm commitment initial public offering of an aggregate 3,000,000 shares of its Class A Ordinary Shares (“the Offering”), all of which are being offered by CUPR</description>
</item>
</channel>
</rss>